Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation

被引:29
|
作者
Gama, Clarissa Severino [1 ,2 ,3 ,4 ]
Berk, Michael [3 ,5 ,6 ]
Andreazza, Ana Cristina [1 ,2 ,7 ]
Kapczinski, Flavio [1 ,2 ,7 ]
Belmonte-de-Abreu, Paulo [1 ,2 ,4 ]
机构
[1] Hosp Clin Porto Alegre, Res Ctr, Mol Psychiat Lab, BR-90035003 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Grad Program Med Psychiat, Porto Alegre, RS, Brazil
[3] Univ Melbourne, Dept Clin & Biomed Sci, Geelong, Vic, Australia
[4] Hosp Clin Porto Alegre, Schizophrenia Program, BR-90035003 Porto Alegre, RS, Brazil
[5] Orygen Res Ctr, Parkville, Vic, Australia
[6] Mental Hlth Res Inst, Parkville, Vic, Australia
[7] Hosp Clin Porto Alegre, Bipolar Disorders Program, BR-90035003 Porto Alegre, RS, Brazil
关键词
Schizophrenia; Brain-derived neurotrophic factor; Superoxide dismutase; Thiobarbituric acid reactive substances; Nerve growth factors;
D O I
10.1590/S1516-44462008000400006
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The neurotrophins, antioxidant enzymes and oxidative markers have reciprocal interactions. This report verified in chronically stable medicated schizophrenic patients whether there are correlations between the serum levels of superoxide dismutase, a key enzyme in the antioxidant defense, thiobarbituric acid reactive substances, a direct index of lipid peroxidation, and brain-derived neurotrophic factor, the most widely distributed neurotrophin. Method: Sixty DSM-IV schizophrenic patients were included (43 males, 17 females). Mean age was 34.7 +/- 10.8 years, mean age at first episode was 19.8 +/- 7.9 years, and mean illness duration was 14.9 +/- 8.5 years. Each subject had a blood sample collected for the determination of serum levels of brain-derived neurotrophic factor, thiobarbituric acid reactive substances and superoxide dismutase. Results: Brain-derived neurotrophic factor levels showed a positive correlation with thiobarbituric acid reactive substances levels (r = 0.333, p = 0.009). Brain-derived neurotrophic factor levels were not correlated with superoxide dismutase levels (r = - 0.181, p = 0.166), and superoxide dismutase levels were not correlated with thiobarbituric acid reactive substances levels (r = 0.141, p = 0.284). Conclusions: The positive correlation between brain-derived neurotrophic factor and thiobarbituric acid reactive substances suggests the need of further investigation on intracellular interactions of neurotrophins, antioxidant enzymes and oxidative markers. In addition, this opens a venue for investigation on treatments for the prevention of neurotoxicity along the course of schizophrenia.
引用
收藏
页码:337 / 340
页数:4
相关论文
共 50 条
  • [41] Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia
    Reis, Helton Jose
    Nicolato, Rodrigo
    Barbosa, Izabela Guimaraes
    Teixeira do Prado, Paulo Henrique
    Ramano-Silva, Marco Aurelio
    Teixiera, Antonio Lucio
    NEUROSCIENCE LETTERS, 2008, 439 (02) : 157 - 159
  • [42] Effects of SSRI or SNRI on serum brain-derived neurotrophic factor levels in depressed patients
    Yoshimura, Reiji
    Sugita, Atsuko
    Hori, Hikaru
    Mitoma, Masae
    Nakamura, Jun
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (05) : A12 - A13
  • [43] Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy
    Costa, Henrique S.
    Lima, Marcia Maria O.
    Figueiredo, Pedro Henrique S.
    Martinelli, Patricia M.
    Camargos, Elizabeth R. S.
    Chaves, Ana Thereza
    Pereira Nunes, Maria Carmo
    Rocha, Manoel Otavio C.
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2018, 113 (10): : e180224
  • [44] Serum levels of brain-derived neurotrophic factor in Sydenham’s chorea
    Antônio Lúcio Teixeira
    Thales Lage Bretas
    Arthur Kummer
    Lívia Cunha Melo
    Amanda Baraldi
    Estefânia Harsányi
    Francisco Cardoso
    Elizabeth Ribeiro da Silva Camargos
    Neurological Sciences, 2010, 31 : 399 - 401
  • [45] Serum levels of brain-derived neurotrophic factor in Sydenham's chorea
    Teixeira, Antonio Lucio
    Bretas, Thales Lage
    Kummer, Arthur
    Melo, Livia Cunha
    Baraldi, Amanda
    Harsanyi, Estefania
    Cardoso, Francisco
    da Silva Camargos, Elizabeth Ribeiro
    NEUROLOGICAL SCIENCES, 2010, 31 (03) : 399 - 401
  • [46] SERUM AND URINARY LEVELS OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) IN ENURESIS
    Kurku, Huseyin
    Soran, Mustafa
    Yar, Ahmet
    Akdam, Neriman
    Arslan, Sukru
    Gonen, Murat
    ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (10): : 1032 - 1037
  • [47] Serum brain-derived neurotrophic factor in patients with trauma psychopathology
    Hauck, Simone
    Kapczinski, Flavio
    Roesler, Rafael
    Silveira, Erico de Moura, Jr.
    Magalhaes, Pedro V.
    Pinto Kruel, Leticia Rosito
    Schestatsky, Sidnei Samuel
    Freitas Ceitlin, Lucia Helena
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (03): : 459 - 462
  • [48] Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet
    Guimaraes, Lisia Rejane
    Jacka, Felice N.
    Gama, Clarissa Severino
    Berk, Michael
    Leitao-Azevedo, Carmen Lucia
    Belmonte de Abreu, Martha Guerra
    Lobato, Maria Ines
    Andreazza, Ana Cristina
    Cereser, Keila Maria
    Kapczinski, Flavio
    Belmonte-de-Abreu, Paulo
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (06): : 1595 - 1598
  • [49] Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases
    Ventriglia, Mariacarla
    Zanardini, Roberta
    Bonomini, Cristina
    Zanetti, Orazio
    Volpe, Daniele
    Pasqualetti, Patrizio
    Gennarelli, Massimo
    Bocchio-Chiavetto, Luisella
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [50] Decreased serum brain-derived neurotrophic factor in unmedicated and medicated bipolar patients during manic and depressive episodes
    Oliveira, G.
    Cereser, K. M.
    Fernandes, B.
    Fries, G. R.
    Stertz, L.
    Aguiar, B.
    Pfaenseller, B.
    Kapczinski, F.
    BIPOLAR DISORDERS, 2009, 11 : 65 - 66